Dexinling
NDC Package 82570-005-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Dexinling is please eat according to the recommended amount,it is not beneficial to eat too much. Marketed by Shenzhen Deyintang Biotechnology Co., Ltd., this product is identified by NDC 82570-005.

Identification & Billing

NDC Package Code
82570-005-01
Package Description
5 g in 1 POUCH
Product Code
82570-005
11-Digit Billing Format
82570000501

Clinical Specifications

Proprietary Name
Dexinling
Dosage Form
-
Usage Information
Please eat according to the recommended amount,it is not beneficial to eat too much.

Regulatory & Marketing

Labeler Name
Shenzhen Deyintang Biotechnology Co., Ltd.
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
02-21-2022
Listing Expiration
12-31-2023
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 82570-005-01 identifies a specific commercial package of 5 g in 1 pouch of Dexinling, labeled by Shenzhen Deyintang Biotechnology Co., Ltd.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Shenzhen Deyintang Biotechnology Co., Ltd. on February 21, 2022. The current certification is valid through December 31, 2023.

How is this Shenzhen Deyintang Biotechnology Co., Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 82570000501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
82570-005-01
11-Digit CMS (5-4-2)
82570-0005-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.